XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression

Doublecortin-like kinase 1 (DCLK1) is a cancer stem cell marker that is highly expressed in various types of human cancer, and a protein kinase target for cancer therapy that is attracting increasing interest. However, no drug candidates targeting DCLK1 kinase have been developed in clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wei-Qiang, Zhao, Wei-Jun, Zhu, Liu-Lian, Xu, Shuai-Jun, Zhang, Xue-Lin, Liang, Yong, Ding, Xiao-Fei, Kiselyov, Alexander, Chen, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982674/
https://www.ncbi.nlm.nih.gov/pubmed/33762936
http://dx.doi.org/10.3389/fphar.2021.603453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982674/
https://www.ncbi.nlm.nih.gov/pubmed/33762936
http://dx.doi.org/10.3389/fphar.2021.603453

Ejemplares similares